Alibaba
BABA
NVIDIA
NVDA
Microsoft
MSFT
Apple
AAPL
ASML Holding
ASML
US Stock MarketDetailed Quotes
CYCN Cyclerion Therapeutics
- 2.7100
- -0.1700-5.90%
Close Feb 20 16:00 ET
7.34MMarket Cap-1.27P/E (TTM)
2.9000High2.6300Low57.00KVolume2.8200Open2.8800Pre Close155.72KTurnover2.92%Turnover RatioLossP/E (Static)2.71MShares9.469952wk High0.90P/B5.29MFloat Cap1.270052wk Low--Dividend TTM1.95MShs Float420.0000Historical High--Div YieldTTM9.38%Amplitude1.2700Historical Low2.7310Avg Price1Lot Size
Cyclerion Therapeutics Key Stats
EPS
According to the latest financial report of Cyclerion Therapeutics, the latest earnings per share (TTM) for the company is -0.29. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Cyclerion Therapeutics's free cash flow? The latest report shows it as -1.72M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Cyclerion Therapeutics shows that the company's current ratio is 5.07, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Cyclerion Therapeutics, the quick ratio is 4.17, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Cyclerion Therapeutics? The latest ROE figure is -8.52%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Cyclerion Therapeutics, the total asset return on investment (ROA) is -7.63%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Cyclerion Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Cyclerion Therapeutics, the net profit margin is -372.68%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.